http://www.sciencedirect.com/science/article/pii/S0014488617300055
Choose an option to locate/access this article:
Check if you have access through your login credentials or your institution
Check accessHighlights
- •
- The neuroprotective compound P7C3-A20 was proposed as a therapeutic for stroke.
- •
- P7C3-A20 reduced sensorimotor and cognitive deficits that occur after stroke.
- •
- P7C3-A20 significantly increased neurogenesis in both neurogenic niches.
- •
- P7C3-A20 significantly reduced both hippocampal and cortical atrophy which was strongly correlated to tissue sparing.
- •
- P7C3-A20 treatment enhanced flux of nicotinamide adenine dinucleotide.
Abstract
Ischemic
stroke is a devastating condition with few therapeutic interventions
available. The neuroprotective compound P7C3-A20 inhibits mature
neuronal cell death while also increasing the net magnitude of postnatal
neurogenesis in models of neurodegeneration and acute injury. P7C3
compounds enhance flux of nicotinamide adenine dinucleotide (NAD) in
mammalian cells, a proposed therapeutic approach to treating cerebral
ischemia. The effectiveness of P7C3-A20 treatment on chronic
histopathological and behavioral outcomes and neurogenesis after
ischemic stroke has not previously been established. Here, a transient
middle cerebral artery occlusion in rats was followed by twice daily
injection of P7C3-A20 or vehicle for 7 days. P7C3-A20-treated rats
performed significantly better than vehicle-treated controls in
sensorimotor cylinder and grid-walk tasks, and in a chronic test of
spatial learning and memory. These behavioral improvements with P7C3-A20
treatment were correlated with significantly decreased cortical and
hippocampal atrophy, and associated with increased neurogenesis in the
subventricular zone and hippocampal dentate gyrus subgranular zone.
Furthermore, cerebral ischemia significantly reduced NAD in the cortex
but P7C3-A20 treatment restored NAD to sham levels. Thus, P7C3-A20
treatment mitigates neurodegeneration and augments repair in the brain
after focal ischemia, which translates into chronic behavioral
improvement. This suggests a new therapeutic approach of using P7C3
compounds to safely augment NAD and thereby promote two independent
processes critical to protecting the brain from ischemic stroke: mature
neuron survival and postnatal hippocampal neurogenesis throughout the
post-ischemic brain.
Keywords
- Aminopropyl carbazole;
- Ischemic stroke;
- Neuroprotection;
- Neurogenesis;
- P7C3-A20;
- NAD
No comments:
Post a Comment